Assyro AI

Orange Book product · Brand (NDA)

ACANYA

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Brand (NDA)NDA 050819TE ABRX BAUSCH

At a glance

Oct 23, 2008

Approved

Brand (NDA)

Application

AB

TE code

6

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 23, 2008

    17 yr 11 mo ago

  2. Today

  3. Patent 10220049 expires

    Listed drug product patent expiration.

    Jun 03, 2029

    in 3 yr

  4. Patent 10624918 expires

    Listed method-of-use patent (U-916) expiration.

    Jun 03, 2029

    in 3 yr

  5. Patent 8663699 expires

    Listed method-of-use patent (U-124) expiration.

    Jun 03, 2029

    in 3 yr

  6. Patent 8895070 expires

    Listed method-of-use patent (U-124) expiration.

    Jun 03, 2029

    in 3 yr

  7. Patent 9078870 expires

    Listed drug product patent expiration.

    Jun 03, 2029

    in 3 yr

  8. Patent 8288434 expires

    Listed drug product patent expiration.

    Aug 05, 2029

    in 3 yr 2 mo

Pharmaceutical detail

Active ingredient

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Strength

2.5%;EQ 1.2% BASE

Dosage form

GEL

Route

TOPICAL

TE code

AB

Application

NDA 050819

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (6)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10220049Jun 03, 2029in 3 yr
ProductU-916
10624918Jun 03, 2029in 3 yr
U-916
8663699Jun 03, 2029in 3 yr
U-124
8895070Jun 03, 2029in 3 yr
U-124
9078870Jun 03, 2029in 3 yr
Product
8288434Aug 05, 2029in 3 yr 2 mo
ProductU-124
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.